Sanna Hellberg

681 total citations
19 papers, 461 citations indexed

About

Sanna Hellberg is a scholar working on Immunology and Allergy, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sanna Hellberg has authored 19 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology and Allergy, 5 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sanna Hellberg's work include Cell Adhesion Molecules Research (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Diabetes Treatment and Management (4 papers). Sanna Hellberg is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Diabetes Treatment and Management (4 papers). Sanna Hellberg collaborates with scholars based in Finland, Netherlands and Sweden. Sanna Hellberg's co-authors include Juhani Knuuti, Antti Saraste, Anne Roivainen, Johanna M. U. Silvola, Heidi Liljenbäck, Seppo Ylä‐Herttuala, Pekka Saukko, Harri Hakovirta, Xiang‐Guo Li and Zhen W. Zhuang and has published in prestigious journals such as Scientific Reports, Arteriosclerosis Thrombosis and Vascular Biology and Clinical Chemistry.

In The Last Decade

Sanna Hellberg

19 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanna Hellberg Finland 11 170 145 130 123 91 19 461
Jenni Virta Finland 12 127 0.7× 106 0.7× 71 0.5× 68 0.6× 79 0.9× 31 390
Dolf Segers Netherlands 12 169 1.0× 71 0.5× 187 1.4× 161 1.3× 175 1.9× 16 617
Luc C.A. van Damme Netherlands 10 127 0.7× 155 1.1× 200 1.5× 145 1.2× 238 2.6× 12 613
E. Fleck Germany 9 177 1.0× 94 0.6× 221 1.7× 37 0.3× 89 1.0× 19 475
Natasja Kisters Netherlands 6 276 1.6× 55 0.4× 129 1.0× 112 0.9× 92 1.0× 7 578
Kunihiko Hatanaka Japan 7 211 1.2× 49 0.3× 163 1.3× 59 0.5× 91 1.0× 11 474
J.L. van Wanroij Netherlands 2 153 0.9× 45 0.3× 82 0.6× 115 0.9× 92 1.0× 4 389
Miikka Tarkia Finland 13 128 0.8× 115 0.8× 126 1.0× 43 0.3× 133 1.5× 27 429
Fatiha Maskali France 13 188 1.1× 97 0.7× 128 1.0× 28 0.2× 120 1.3× 30 557
Beatriz Herránz Spain 8 97 0.6× 32 0.2× 60 0.5× 102 0.8× 58 0.6× 8 384

Countries citing papers authored by Sanna Hellberg

Since Specialization
Citations

This map shows the geographic impact of Sanna Hellberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanna Hellberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanna Hellberg more than expected).

Fields of papers citing papers by Sanna Hellberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanna Hellberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanna Hellberg. The network helps show where Sanna Hellberg may publish in the future.

Co-authorship network of co-authors of Sanna Hellberg

This figure shows the co-authorship network connecting the top 25 collaborators of Sanna Hellberg. A scholar is included among the top collaborators of Sanna Hellberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanna Hellberg. Sanna Hellberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kumawat, Ashok Kumar, Mulugeta M. Zegeye, Geena Varghese Paramel, et al.. (2022). Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice. Frontiers in Cardiovascular Medicine. 9. 831039–831039. 1 indexed citations
2.
Ståhle, Mia, Sanna Hellberg, Jenni Virta, et al.. (2021). Evaluation of glucagon-like peptide-1 receptor expression in nondiabetic and diabetic atherosclerotic mice using PET tracer Ga-68-NODAGA-exendin-4. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
3.
Ståhle, Mia, Sanna Hellberg, Jenni Virta, et al.. (2021). Evaluation of glucagon-like peptide-1 receptor expression in nondiabetic and diabetic atherosclerotic mice using PET tracer 68Ga-NODAGA-exendin-4. American Journal of Physiology-Endocrinology and Metabolism. 320(5). E989–E998. 8 indexed citations
4.
Ståhle, Mia, Johanna M. U. Silvola, Sanna Hellberg, et al.. (2020). Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Atherosclerotic Mice. JACC Basic to Translational Science. 5(4). 360–373. 10 indexed citations
5.
Virta, Jenni, Sanna Hellberg, Heidi Liljenbäck, et al.. (2020). Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes. Atherosclerosis. 305. 64–72. 5 indexed citations
6.
Hellberg, Sanna, Johanna M. U. Silvola, Heidi Liljenbäck, et al.. (2019). Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques. Molecules. 24(6). 1072–1072. 9 indexed citations
7.
Hellberg, Sanna, Meeri Käkelä, Heidi Liljenbäck, et al.. (2018). Evaluation of [68Ga]Ga-DOTA-TCTP-1 for the Detection of Metalloproteinase 2/9 Expression in Mouse Atherosclerotic Plaques. Molecules. 23(12). 3168–3168. 15 indexed citations
8.
Hellberg, Sanna, Heidi Liljenbäck, Olli Eskola, et al.. (2018). Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with18F-GE-180, a Radiotracer for Translocator Protein (TSPO). Contrast Media & Molecular Imaging. 2018. 1–11. 31 indexed citations
9.
Hellberg, Sanna, Suvi Sippola, Heidi Liljenbäck, et al.. (2017). Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [18F]FDG uptake in Ldlr−/−Apob mice. Atherosclerosis. 263. 369–376. 17 indexed citations
10.
Virtanen, Helena E., Johanna M. U. Silvola, Anu Autio, et al.. (2017). Comparison of 68Ga-DOTA-Siglec-9 and 18F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry. Contrast Media & Molecular Imaging. 2017. 1–10. 4 indexed citations
11.
Ståhle, Mia, Sanna Hellberg, Jenni Virta, et al.. (2017). Positron emission tomography tracer [68GA]NODAGA-EXENDIN-4 detects glucagon-like peptide-1 receptor expression in mouse atherosclerotic vascular lesions. Atherosclerosis. 263. e55–e56. 1 indexed citations
12.
Hellberg, Sanna, Johanna M. U. Silvola, Heidi Liljenbäck, et al.. (2016). Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer 18F-fluoromethylcholine. Cardiovascular Diabetology. 15(1). 26–26. 26 indexed citations
13.
Silvola, Johanna M. U., Helena E. Virtanen, Sanna Hellberg, et al.. (2016). Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques. Scientific Reports. 6(1). 35089–35089. 31 indexed citations
14.
Hellberg, Sanna, Johanna M. U. Silvola, Heidi Liljenbäck, et al.. (2016). 18-kDa translocator protein ligand 18F-FEMPA: Biodistribution and uptake into atherosclerotic plaques in mice. Journal of Nuclear Cardiology. 24(3). 862–871. 40 indexed citations
15.
Rinne, Petteri, Sanna Hellberg, Jenni Virta, et al.. (2015). Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques. Molecular Imaging and Biology. 18(1). 99–108. 46 indexed citations
16.
Kivelä, Riikka, Maija Bry, Marius R. Robciuc, et al.. (2014). VEGF ‐B‐induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Molecular Medicine. 6(3). 307–321. 132 indexed citations
17.
Rinne, Petteri, Johanna M. U. Silvola, Sanna Hellberg, et al.. (2014). Pharmacological Activation of the Melanocortin System Limits Plaque Inflammation and Ameliorates Vascular Dysfunction in Atherosclerotic Mice. Arteriosclerosis Thrombosis and Vascular Biology. 34(7). 1346–1354. 23 indexed citations
18.
Twarda‐Clapa, Aleksandra, et al.. (2013). Epitope Specificity and IgG Subclass Distribution of Autoantibodies to Cardiac Troponin. Clinical Chemistry. 59(3). 512–518. 20 indexed citations
19.
Laitinen, Iina, Pauliina Luoto, Kjell Någren, et al.. (2010). Uptake of 11C-Choline in Mouse Atherosclerotic Plaques. Journal of Nuclear Medicine. 51(5). 798–802. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jenni Virta Breakdown of academic impact, for papers by Dolf Segers Breakdown of academic impact, for papers by Luc C.A. van Damme Breakdown of academic impact, for papers by E. Fleck Breakdown of academic impact, for papers by Natasja Kisters Breakdown of academic impact, for papers by Kunihiko Hatanaka Breakdown of academic impact, for papers by J.L. van Wanroij Breakdown of academic impact, for papers by Miikka Tarkia Breakdown of academic impact, for papers by Fatiha Maskali Breakdown of academic impact, for papers by Beatriz Herránz
Rankless by CCL
2026